Related Experiment Video
Updated: Oct 18, 2025
Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
Mesoporous Aerogel Microparticles Injected into the Abdominal Cavity of Mice Accumulate in Parathymic Lymph Nodes
Gábor Király1, John Chinonso Egu2, Zoltán Hargitai3
1Department of Molecular Biotechnology and Microbiology, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.
Abstract:
Mesoporous aerogel microparticles are promising drug delivery systems. However, their in vivo biodistribution pathways and health effects are unknown. Suspensions of fluorescein-labeled silica-gelatin hybrid aerogel microparticles were injected into the peritoneum (abdominal cavity) of healthy mice in concentrations of 52 and 104 mg kg-1 in a 3-week-long acute toxicity experiment. No physiological dysfunctions were detected, and all mice were healthy. An autopsy revealed that the aerogel microparticles were not present at the site of injection in the abdominal cavity at the end of the experiment. The histological study of the liver, spleen, kidneys, thymus and lymphatic tissues showed no signs of toxicity. The localization of the aerogel microparticles in the organs was studied by fluorescence microscopy. Aerogel microparticles were not detected in any of the abdominal organs, but they were clearly visible in the cortical part of the parathymic lymph nodes, where they accumulated. The accumulation of aerogel microparticles in parathymic lymph nodes in combination with their absence in the reticuloendothelial system organs, such as the liver or spleen, suggests that the microparticles entered the lymphatic circulation. This biodistribution pathway could be exploited to design passive targeting drug delivery systems for flooding metastatic pathways of abdominal cancers that spread via the lymphatic circulation.
Insights
Silica-gelatin aerogel microparticles show no toxicity in mice and are cleared from the abdomen. These promising drug delivery systems accumulate in lymph nodes, suggesting potential for cancer targeting via lymphatic circulation.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Mesoporous aerogel microparticles are advanced drug delivery platforms.
- Their in vivo behavior and safety profiles remain largely uncharacterized.
Purpose of the Study:
- To investigate the in vivo biodistribution and acute toxicity of silica-gelatin hybrid aerogel microparticles.
- To assess the potential of these microparticles for targeted drug delivery.
Main Methods:
- Fluorescein-labeled aerogel microparticles were administered intraperitoneally to healthy mice.
- Acute toxicity was evaluated over 3 weeks, with physiological monitoring and histopathological analysis.
- Microparticle localization was determined using fluorescence microscopy.
Main Results:
- No physiological dysfunctions or signs of toxicity were observed in mice.
- Aerogel microparticles were absent from the injection site and major organs (liver, spleen, kidneys) post-experiment.
- Significant accumulation of microparticles was detected in parathymic lymph nodes, indicating lymphatic circulation uptake.
Conclusions:
- Silica-gelatin aerogel microparticles exhibit a favorable safety profile and are cleared from the peritoneal cavity.
- Their preferential accumulation in lymph nodes suggests a potential for developing passive drug targeting strategies for lymphatic metastatic cancers.
